Showing results (121-130 of 296) with videos related to
Sort By:
Pageof 30
Cancer Research|March 18, 2010
Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancerYongfen Min, Xiubao Ren, David B Vaught, et al.Cell Death & Disease|June 19, 2019
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and humanQian Sun, Xiying Zhang, Limei Wang, et al.Cancer Biology & Medicine|May 24, 2019
Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patientsCihui Yan, Jingjing Chang, Xinmiao Song, et al.Breast Care (Basel, Switzerland)|September 30, 2010
Quality of Life after Autologous Peripheral Blood Stem Cell Transplantation and High-Dose Chemotherapy in High-Risk Breast Cancer PatientsLi Zhang, Zhongsheng Tong, Shufen Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2014
Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancerJinpu Yu, Yue Wang, Fang Yan, et al.Journal of Cancer|November 22, 2017
Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell LineLili Yang, Chunjuan Du, Lei Wu, et al.Journal of Breast Cancer|July 3, 2018
Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast CancerMan Li, Yang Wang, Feng Wei, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2026
OX40+ regulatory T cells suppress neoadjuvant chemotherapy response in NSCLC and reversed by combination of PD-1 blockade therapyJiali Zhang, Rui Liu, Qingqing Hui, et al.Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Fetal-maternal microchimerism enhances the survival effect of interleukin-2-activated haploidentical peripheral blood stem cell treatment in patients with advanced solid cancerYing Han, Jinpu Yu, Shui Cao, et al.Future Oncology (London, England)|August 16, 2016
Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancerYing Han, Jing Wang, Liping Hong, et al.Pageof 30